Class & Mechanism
Ovagen is a peptide therapy that functions as a hepatic or liver bioregulator. It is designed to support and stimulate the regeneration of liver cells, thereby enhancing the overall function and health of the liver. The exact mechanism by which Ovagen achieves this effect is not explicitly detailed in the provided excerpts, but it is presumed to involve interaction with specific receptors or cellular pathways within the hepatic system.
Research-documented benefits
Local corpus: silent.
General-knowledge benefits
Ovagen is believed to have hepatoprotective properties, potentially reducing liver damage caused by various toxins or diseases. It may also play a role in the regeneration of liver tissue post-injury or after surgical procedures. The peptide is thought to be particularly useful in conditions where liver function is compromised, such as in certain types of liver disease or following exposure to hepatotoxic substances.
Typical injectable protocol
The typical injectable protocol for Ovagen is not well-defined in the literature. However, based on its classification as a peptide therapy, it is generally administered subcutaneously (SC) or intramuscularly (IM) in the range of micrograms (µg) per dose, with treatment cycles varying depending on the condition being treated and the individual patient's response.
Key risks / contraindications
As with any peptide therapy, there is a potential risk of allergic reaction or anaphylaxis. Ovagen should not be used in patients with a known hypersensitivity to the peptide or any of its components. Additionally, its use in pregnant or breastfeeding women is not recommended due to a lack of safety data.
Bottom line
Ovagen is a peptide therapy that may support liver health and regeneration, but its use is primarily investigational at this stage, and more research is needed to fully understand its mechanisms and establish its safety and efficacy profile.
References
- Adenoviruses_ Basic Biology to Gene Therapy
- Advances in drug delivery
- Antioxidants and redox signaling_ impact on NF-κB and Nrf2
- Antisense Research and Application
- Antisense oligonucleotides_ the state of the art
- Biomaterials Science_ An Introduction to Materials in Medicine
- Cancer_ Principles & Practice of Oncology
- Cells, Aging, and Human Disease
- Chemical Biology of Nucleic Acids
- Gene Therapy_ Therapeutic Mechanisms and Strategies
- Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
- Inclisiran in patients at high cardiovascular risk
- Medicinal Chemistry of Anticancer Drugs
- Mitochondrial Medicine_ Volume II, Manipulating Mitochondrial Function
- Oxidative Stress and Inflammation in Non-communicable Diseases_ Molecular Mechanisms and Perspectives in Therapeutics
- Peptide Bioregulators in Gerontology
- Peptide Therapeutics_ Design and Development
- Peptides and Non Peptides of Oncologic and Endocrine Interest
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Principles and Practice of the Biologic Therapy of Cancer
- Prodrugs_ Challenges and Rewards
- RNA Interference Technology
- RNA Interference_ From Biology to Clinical Applications
- RNA Therapeutics_ Function, Design, and Delivery
- Sirtuins and NAD br sup + sup br
- The Metabolic Role of Phosphate